Market Survey on Aflatoxicosis Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Aflatoxicosis Treatment Market including Blood Transfusion, Oxygen Therapy, Antibiotics, Antihistamines, and Immunosuppressants Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
As per the analysis, the global aflatoxicosis treatment market is expected to secure US$ 279.5 million in 2023 and reach US$ 407.6 million by 2033. The market is estimated to secure a CAGR of 3.8% during the forecast period. Growing instances of foodborne illness are expected to play a key role in driving the market growth during the forecast period.
As per World Health Organization, aflatoxins pose a significant economic challenge by ruining more than 25% of the world’s grain annually. Developing countries like India suffer significantly owing to the lack of storage facilities, eventually resulting in exposure to toxins like aflatoxins. According to a recent National Academy of Agricultural Sciences, India study, lack of storage facility is the most important cause of post-harvest losses for all types of food in India.
However, the market can rise with growing favorable initiatives such as the SVAMITVA scheme. The scheme digitally empowers Gram Panchayats by engaging the latest surveying technologies to digitally map and record other properties. The market is projected to witness notable development in the forecast period due to such factors.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Factors Supporting Global Market Growth?
Increasing awareness about aflatoxins is expected to support the market growth during the forecast period. There have been various studies on the subject, which are expected to propel market growth in the coming period. Enhanced awareness about grain storage facilities is another salient factor supporting the market expansion in the coming period.
Developing countries are taking several initiatives to address the situation, a significant factor supporting industry growth in the forecast period. Also, modern grain storage facilities is estimated to further augment the market size in the coming time.
Additionally, stringent government rules on mycotoxin detection are expected to develop the industry in the forecast period. More than 100 countries have formal mycotoxin regulations for feed and food. EU has the most stringent rules, where several organizations and pan-European networks work to combat the challenges associated with the toxin.
In May 2006, in Kenya, an outbreak of acute aflatoxicosis was reported, where aflatoxin contamination of homegrown corn had become a recurring issue. In collaboration with the Kenya government, CDC worked on the trial of a portable, rapid aflatoxin screening tool that could be utilized in the field to recognize contaminated corn and suggest urgent corn replacement directions during an outbreak. Thus, owing to the factors above, the market is estimated to likely witness significant future growth.
What Factors are Challenging the Growth of the Global Market?
In developing countries, a lack of advanced technologies, infrastructure, and resources is expected to impede market expansion during the forecast period. Other issues associated with the market, such as scarce resources, poor management, and limited technology, may impede market growth in the future. Furthermore, the need for more support for developing countries from organizations such as the World Health Organization, the Food and Agriculture Organization, and the World Bank is likely to aggravate the situation.
However, with the rising food trade in developing countries, the market is expected to see some growth. Furthermore, rising mycotoxin outbreaks in emerging markets such as Asia and Africa are expected to offer lucrative opportunities to the market during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Sales Analysis of the Aflatoxicosis Treatment Market from 2018 to 2022 Vs Market Outlook for 2023 to 2033
The global demand for Aflatoxicosis Treatment is slated to grow at a moderate CAGR of 3.8% during the forecast period, totaling over US$ 407.6 million by 2033. Increased concerns about aflatoxins are expected to contribute to market growth.
Several studies on the subject have been conducted, and they are predicted to influence market growth in the coming years. The global demand for Aflatoxicosis Treatment grew at a moderate CAGR of 2.7% with a valuation of US$ 237.1 million in 2018 and US$ 271.2 million in 2022.
Enhanced awareness regarding grain storage facilities is another salient factor facilitating the market expansion in the upcoming years. Developing countries are taking various steps to deal with the situation, a large determinant supporting industry growth during the forecast period. Furthermore, modern grain storage facilities is estimated to increase market size shortly.
Furthermore, the industry is anticipated to develop during the forecast period due to stringent government regulations on mycotoxin detection. More than 100 countries currently have formal mycotoxin regulations for feed and food.
An outbreak of acute aflatoxicosis was reported in Kenya in May 2006, where aflatoxin contamination of homegrown corn had emerged as a recurring issue.
In collaboration with the Kenyan government, the CDC tested a portable, rapid aflatoxin screening tool that could be used in the field to identify contaminated corn and suggest urgent corn suitable alternative directions during an outbreak. Thus, owing to the components above, the market also experienced significant growth in the historical period.
Region-Wise Insights
Countries
Market Value Share in 2023
United States
34.4%
Germany
6.2%
Japan
3.4%
Countries
Market CAGR Value in 2023
China
3.1%
India
3.5%
United Kingdom
3.3%
Australia
2.7%
Why is the Asia Pacific is Driving the Global Market?
According to the analysis, the market in the Asia Pacific is expected to develop faster and provide lucrative opportunities during the forecast period. The presence of developing countries such as India, China, and Japan has contributed to the market's growth. During the assessment period, these countries' governments impose various initiatives that can support market growth.
The Chinese government strives to ensure global food safety regulations and standards compliance. The Food Safety and Standards Authority of India (FSSAI) inspects the quality of food products in India. With the presence of such authorities in developing countries, the Asia Pacific market is likely to expand rapidly during the forecast period.
Countries like India and China are obtaining government assistance for financing and developing cutting-edge technologies. These emerging economies' regulatory bodies are using their resources to construct infrastructure and upgrade technology to create high-growth opportunities for Aflatoxicosis Treatment in Asia.
Why is North America Emerging as a Promising Market for Aflatoxicosis Treatment?
According to the analysis, the North American market is estimated to possess a 36.6% market share by 2033. The market's expansion can be due to increasing concerns about food safety and increasing awareness about toxins.
Ongoing research and development on the subject are likely to provide significant market growth opportunities. For example, Mars Inc. in the United States has launched a three-year project titled "Identification of markers and genomic regions associated with aflatoxin resistance in groundnut." This survey aims to validate the identified genes and generate diagnostic markers for molecular breeding to produce fine lines with better aflatoxin resistance.
According to a recent research report by FMI, the 'corn belt' region of the United States is estimated to likely face increased problems with aflatoxins shortly. Field corn, as opposed to sweet corn, is widely consumed in the United States and is one of the important crops, so North America is estimated to witness a huge demand for aflatoxicosis treatment in the forthcoming years.
What is the Growth Projection for the Europe Aflatoxicosis Treatment Market?
Maize is a concern for mycotoxin contamination among staple crops; mycotoxins are regulated in Europe and several other countries worldwide, and several co-occurring fungal organisms are abundantly found. With a mandate to identify emerging risks in the food and feed sectors, the European Food Safety Authority (EFSA) has identified changing patterns in mycotoxin production in cereals due to CC as a potential source of concern.
The EU has stringent rules, and several organizations and pan-European networks cooperate in combating the toxin's challenges. Aflatoxin (AF) contamination in maize is also expected to increase due to climate change (CC).
Consequently, such factors are expected to contribute to substantial growth in the European market during the forecast period. Europe is estimated to account for around 27.6% of the global market by 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
The Start-up Ecosystem: How Key Players are Opening Frontiers for Future Growth?
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
Shandong Meizheng Bio-Tech Co., Ltd. was founded in 2017. They have been producing medicines for the treatment of Aflatoxicosis.
Beijing Kwinbon Biotechnology Co., Ltd., founded in 2002 at China Agricultural University (CAU), is a manufacturer and retailer of Aflatoxicosis Treatment medicines and test kits.
Who are the Leading Players in Aflatoxicosis Treatment Market?
Some leading Aflatoxicosis Treatment manufacturers include Pfizer Inc., Sanofi, Abbott Laboratories, Zydus Cadilla, Glaxo Smith Kline, and Johnson and Johnson.
Because of the presence of regional and domestic players, the global market is highly competitive. To capitalize, leading enteral feeding device manufacturers implement a wide range of tactics such as new product launches and approvals, collaborations, partnerships, acquisitions, and strengthening of the distribution channel. As an example,
CEVA has worked for over 20 years against mycotoxins, formerly as part of SANOFI animal health division. They manufacture and provide medicines for Aflatoxicosis.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, primarily engaged in manufacturing generic drugs for aflatoxicosis treatment.
Scope of Report
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2022
Market Analysis
US$ billion for Value
Key Countries Covered
United States, United Kingdom, Japan, India, China, Australia, Germany
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Aflatoxicosis Treatment Market by Category
By Treatment:
Blood Transfusion
Oxygen Therapy
Antibiotics
Antihistamines
Immunosuppressants
Others
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Frequently Asked Questions
What are the Top Content Delivery Network (CDN) Companies?
Akamai, CloudFlare, and Microsoft are the top companies in the global market.
How Big is the Aflatoxicosis Treatment Market?
The global market is valued at US$ 279.5 million in 2023.
What is the Projected Size of the Aflatoxicosis Treatment Market in Ten Years?
The adoption of Aflatoxicosis treatments could be around US$ 407.6 million by 2033.
Which is the Leading Regional Market for Aflatoxicosis Treatment in Europe?
Germany dominates the region and accounted for 6.2% market share in 2022.
How Big is the Aflatoxicosis Treatment Market in the United States?
The United States Market contributed for roughly 34.4% of the global revenue in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033
5.3.1. Blood Transfusion
5.3.2. Oxygen Therapy
5.3.3. Antibiotics
5.3.4. Antihistamines
5.3.5. Immunosuppressants
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Treatment, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. USA
7.2.1.2. Canada
7.2.2. By Treatment
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Treatment
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Treatment
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Treatment
8.4. Key Takeaways
9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. UK
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Treatment
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Treatment
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Treatment
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2023
12.1.2.1. By Treatment
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2023
12.2.2.1. By Treatment
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2023
12.3.2.1. By Treatment
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2023
12.4.2.1. By Treatment
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2023
12.5.2.1. By Treatment
12.6. UK
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2023
12.6.2.1. By Treatment
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2023
12.7.2.1. By Treatment
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2023
12.8.2.1. By Treatment
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2023
12.9.2.1. By Treatment
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2023
12.10.2.1. By Treatment
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2023
12.11.2.1. By Treatment
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2023
12.12.2.1. By Treatment
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2023
12.13.2.1. By Treatment
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2023
12.14.2.1. By Treatment
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2023
12.15.2.1. By Treatment
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2023
12.16.2.1. By Treatment
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2023
12.17.2.1. By Treatment
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2023
12.18.2.1. By Treatment
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2023
12.19.2.1. By Treatment
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Treatment
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Pfizer Inc.
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Sanofi
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Zydus Cadilla
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Abbott Laboratories
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Glaxo Smith Kline
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Johnson and Johnson
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Elanco Animal Health Incoproration
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Merck & CO. Inc
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Virbac
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Bayer AG
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used16. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 3: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 5: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: Latin America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 7: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Europe Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 9: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Asia Pacific Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 11: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 12: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 3: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 4: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 5: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 6: Global Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 9: Global Market Attractiveness by Treatment, 2023 to 2033
Figure 10: Global Market Attractiveness by Region, 2023 to 2033
Figure 11: North America Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 12: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 13: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 16: North America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 17: North America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 18: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 19: North America Market Attractiveness by Treatment, 2023 to 2033
Figure 20: North America Market Attractiveness by Country, 2023 to 2033
Figure 21: Latin America Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 22: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 23: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 26: Latin America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 27: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 29: Latin America Market Attractiveness by Treatment, 2023 to 2033
Figure 30: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 31: Europe Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 32: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 33: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 36: Europe Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 37: Europe Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 38: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 39: Europe Market Attractiveness by Treatment, 2023 to 2033
Figure 40: Europe Market Attractiveness by Country, 2023 to 2033
Figure 41: Asia Pacific Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 42: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 43: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 46: Asia Pacific Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 49: Asia Pacific Market Attractiveness by Treatment, 2023 to 2033
Figure 50: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 51: Middle East and Africa Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 52: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 53: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 56: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 59: Middle East and Africa Market Attractiveness by Treatment, 2023 to 2033
Figure 60: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
